Evaluation of the Risk of VTE Among Patients Hospitalized in Non-surgical Departments
The Risk for VTE Among Patients in the Medical Wards - Prospective Observational Study.
1 other identifier
observational
4,000
0 countries
N/A
Brief Summary
Patients hospitalized in internal wards are at risk for VTE. The current guidelines recommend the use of thromboprophylaxis for 7-10 days among patients who are at increased risk for VTE. Yet several retrospective studies have shown that the compliance with this guideline is low. Physicians are often reluctant to administer LMWH to their fragile patients mainly because they are not convince that the risk associated with such therapy is greater than the risk for VTE. In the current study, data concerning the use of thromboprophylaxis among patients admitted to the medical wards will be collected. The occurrence of bleeding or thrombotic event will be evaluated prospectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 3, 2017
CompletedFirst Posted
Study publicly available on registry
March 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedJune 12, 2018
March 1, 2018
7.3 years
March 3, 2017
June 11, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
Thrombosis
Rate of thrombotic events within 90 days following discharge
90 days
Bleeding
Rate of minor and major bleeding episodes within 90 days following discharge
90 days
Compliance
Rate of compliance with ACCP guidelines concerning thromboprophylaxis of non-surgical patients.
90 days
Eligibility Criteria
Patients admitted to the medical wards at the Hadassah University Hospital
You may qualify if:
- Patients admitted to the medical wards at the Hadassah University Hospital
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2017
First Posted
March 8, 2017
Study Start
August 1, 2013
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
June 12, 2018
Record last verified: 2018-03